Apnimed investor converts notes and buys stock
Morningside Venture Investments Ltd, a 10% owner of Apnimed, Inc., reported IPO-related restructuring transactions and a share purchase.
Rhea-AI Filing Summary
Morningside Venture Investments Ltd, a 10% owner of Apnimed, Inc., reported IPO-related restructuring transactions and a share purchase. Convertible preferred stock automatically converted into 6,840,213 shares of Class A Common Stock immediately prior to the IPO closing, then Class A was reclassified into common stock in a transaction described as exempt under Rule 16b-7. A $1,000,000 convertible promissory note, bearing 8% then 15% interest, automatically converted into 75,624 Class A shares at a $14.40 conversion price based on an IPO price of $16 per share. In addition, the reporting person purchased 312,500 shares of common stock at $16 per share in an open-market or private transaction. Certain shares are held indirectly through MVIL, LLC, and Morningside’s directors share voting and dispositive power and disclaim beneficial ownership.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Convertible Preferred Stock F1, F2 | 9,227,454 | $0.00 | $0.00 |
| Conversion | Convertible Promissory Note F4, F5, F2, F6 | 1,088,986.3 | $0.00 | $0.00 |
| Conversion | Class A Common Stock F1, F2 | 6,840,213 | -- | -- |
| Other | Class A Common Stock F3, F2 | 6,840,213 | -- | -- |
| Other | Common Stock F3, F2 | 6,840,213 | -- | -- |
| Purchase | Common Stock F2 | 312,500 | $16.00 | $5.00M |
| Conversion | Class A Common Stock F4, F2, F6 | 75,624 | $14.40 | $1.09M |
| Other | Class A Common Stock F3, F2, F6 | 75,624 | -- | -- |
| Other | Common Stock F3, F2, F6 | 75,624 | -- | -- |
Footnotes (6)
- F1. Each share of convertible preferred stock ("Convertible Preferred Stock") was convertible into one share of Class A common stock ("Class A Common Stock") at any time at the option of the holder into such number of fully paid and non-assessable shares of Class A Common Stock as was determined by dividing the original issuance price of each series of Convertible Preferred Stock by each series' conversion price in effect at the time of conversion. The Convertible Preferred Stock reported herein automatically converted immediately prior to the closing of the Issuer's initial public offering (the "IPO") into 6,840,213 shares of Class A Common Stock without payment of additional consideration. The Convertible Preferred Stock had no expiration date.
- F2. Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC, Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards, and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL, LLC.
- F3. Following the conversion of all outstanding shares of the Issuer's Convertible Preferred Stock, Class B common stock, Class C common stock, and Convertible Promissory Notes (the "Notes") into shares of Class A Common Stock immediately prior to the closing of the IPO, each share of Class A Common Stock was then reclassified into one share of common stock ("Common Stock") in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to Rule 16b-7 thereunder (the "Reclassification").
- F4. The Notes were originally issued on September 17, 2025, with the Reporting Person acquiring a Note with a principal amount of $1,000,000. The Notes earned interest at a rate of 8% annually until March 31, 2026, and thereafter earned interest at a rate of 15% annually until repaid or converted. The Notes included a conversion feature providing for automatic conversion into Class A Common Stock at or immediately prior to the closing of the IPO at a 10% discount to the IPO price per share. As a result of the IPO pricing on July 30, 2026, at a price of $16 per share, this Note automatically converted into shares of Class A Common Stock immediately prior to the closing of the IPO on August 3, 2026, at a conversion price of $14.40.
- F5. The Notes were scheduled to mature on September 17, 2027, but converted automatically upon the closing of the IPO on August 3, 2026, prior to the maturity date.
- F6. Represents securities held by MVIL, LLC.
Key Figures
Key Terms
Convertible Preferred Stock financial
Convertible Promissory Notes financial
Reclassification financial
Section 16(b) regulatory
Rule 16b-7 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Morningside report in its Form 4 for Apnimed (APMD)?
What were the terms of the Apnimed (APMD) convertible promissory note?
What common stock purchase did Morningside make in Apnimed (APMD)?
AI-generated analysis. How Rhea-AI works. Not financial advice.